|
|
||||||||
Departments of Radiology, Nuclear Section and Internal Medicine, Division of Infectious Disease, The University of Texas Medical Branch, Galveston, Texas
Correspondence: For correspondence or reprints contact: Martin L. Nusynowitz, MD, Department of Radiology, Nuclear Medicine Section 07933, 01 University Blvd., Galveston, TX 77555-0793.
ABSTRACT
This article explores the accumulation of 99mTc-tetraphenyl porphyrin sulfonate (TPPS4) at inflammatory sites, especially osteomyelitis, and compares the results with 111In CI3 and 111In-WBC-WBCin an animal model. Methods: Osteomyelitis was induced in 12 New Zealand white rabbits by injecting staphylococcus aureus in the left tibia. Three weeks later, radiographs confirmed the disease. Two hours later, after injection of 74 MBq 99mTc-TPPS4, scintiphotos of the lower extremities were acquired and repeat scintiphotos were ob tained 24 hr after injection of 5.55 MBq 111InCI3. After these studies, 24-and 48-hr scintiphotos of the lower extremities were acquired after injecting 5.55 MBq 111In-labeledWBC. Results: The left tibia averaged three times the uptake with 99mTc-TPPS4 compared with right tibia; with 111In CI3 and 111In WBC the ratios are two times. These three radiopharmaceuticals reveal positive images, but the image quality using 99mTc-TPPS4 is better, as would be expected from the more favorable physical characteristics of 99mTc and the higher uptake. Conclusion: The traditional combination of three-phase bone and 67Ga-citrate scintigraphy can be replaced by a single injection of 99mTc-TPPS4with imaging as early as 2 hr. Finally, the use 99mTc-TPPS4 should result in a substantial reduction in radiopharmaceutical cost.
Key Words: osteomyelitis technetium-99m-tetraphenyl porphyrin sulfonate indium-111 white blood cells
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |